UPA Dual Pathway Metabolic Research Vial – UPZEP 60 (60mg Total)
Product Overview
The UPA Dual Pathway Metabolic Research Vial – UPZEP 60 is a high-purity, lyophilised peptide research compound supplied in vial format for laboratory and analytical research.
This formulation contains a dual-pathway incretin-based research compound commonly referenced in metabolic, glucose-regulation, and appetite-signalling studies.
Compound Information (Research Context Only)
This vial contains:
60mg dual-pathway incretin research compound
In research literature, this compound is frequently studied for its role in:
Appetite and satiety signalling pathways
Glucose and insulin regulation mechanisms
Energy balance and metabolic efficiency
Multi-receptor hormone signalling models
Format & Handling
Lyophilised (freeze-dried) research compound
Supplied in sterile vial format
Intended for controlled laboratory handling
Suitable for analytical, educational, and experimental research
Intended Audience
This product is intended for:
Research professionals
Laboratories and institutions
Experienced compound handlers
Educational or analytical research use
Important Notice
This product is not intended for personal, cosmetic, or therapeutic use.
Primary Disclaimer
This product is not intended to diagnose, treat, cure, or prevent any disease.
Research Disclaimer
All peptide products are sold strictly for laboratory and research purposes only.
No medical, therapeutic, or weight-loss claims are made or implied.